GL1X · GenesisL1 explorer

MolNFT v1 · #116889 · protein

Structure of the AALPXC/LPC-023 complex

5DRP · Udp-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase: “Structure of the AALPXC/LPC-023 complex”. X-ray diffraction, 3 ligands (5EP, ZN, CL), 4 pockets (best druggability 0.83). MolNFT v1 #116889 on GenesisL1: 3D structure…

PDB
5DRP
Type
protein
Length
534 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Udp-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase
EC
3.5.1.-
UniProt
O67648
Ligands
5EP, ZN, CL
Pockets
4 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BUdp-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (EC 3.5.1.-)protein26724% helix, 34% strandO67648

Ligands and binding sites

  • 5EP · N~2~-{4-[4-(4-aminophenyl)buta-1,3-diyn-1-yl]benzoyl}-N-hydroxy-L-isoleucinamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • CL · Chloride ion · ion · chains B
  • DMS · Dimethyl sulfoxide · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111730.830.841065EP
25020.730.82435EP, CL, DMS
3750.400.7920empty
4530.350.7918empty

Interfaces

1 interface between chains.

  • A–B · 744 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 5DRP · Structure of the AaLpxC/LPC-023 Complex · the same entry in another collection · chain A against A, TM-score 1.00
  • O67648 · AlphaFold monomer V2.0 prediction for udp-3-O-acyl-N- acetylglucosamine deacetylase… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.